TrialJournal of acquired immune deficiency syndromes (1999)2009

Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission.

Dara A Lehman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.